• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND ALTRUA; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND ALTRUA; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number S203
Medical Device Problem Codes Premature Discharge of Battery (1057); Capturing Problem (2891)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 08/08/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.
 
Event or Problem Description
Additional information was received indicating that the device was explanted.
 
Additional Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event or Problem Description
Boston scientific received information that this pacemaker had reached elective replacement indicator (eri).A month before the pacemaker reached eri, the battery status showed two years remaining and the right ventricular (rv) output was at 6.5 volts.Boston scientific technical services (ts) explained this could be normal battery depletion (nbd) due to the increased in rv output.Ts advised to have device data analysis however, the health care professional (hcp) declined.Additional information was received indicating that eri was confirmed and that the patient was scheduled for device changeout.To date pacemaker still remains in service.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, detailed mechanical and electrical testing was performed on the device.The device battery status was elective replacement time (ert).The device functioned normally throughout testing.Laboratory analysis determined that this device experienced normal battery depletion; however, the estimated longevity remaining value appeared to decrease more quickly than expected between routine follow-ups.Factors influencing the estimated longevity remaining calculation include pacing rate, amplitude, pulse-width and lead impedance.Any even slight changes in these factors will impact the battery consumption calculation and therefore the remaining longevity estimate.Please note that, despite the drop in estimated longevity remaining, the actual battery condition did not change significantly between follow-ups.In summary, it was determined that this device experienced normal battery depletion, but declared ert earlier than previously estimated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTRUA
Common Device Name
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
MDR Report Key6296674
Report Number2124215-2016-18678
Device Sequence Number11039252
Product Code LWP
UDI-Device Identifier00802526484391
UDI-Public(01)00802526484391(17)20130126
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2016
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/26/2013
Device Model NumberS203
Other Device ID NumberALTRUA 20
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/22/2016
Was the Report Sent to FDA? Yes
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 11/29/2016
Supplement Date Received by ManufacturerNot provided
Not provided
Initial Report FDA Received Date02/02/2017
Supplement Report FDA Received Date02/02/2017
04/27/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
(B)(4); (B)(4); (B)(4); (B)(4); (B)(4)
Patient Age85 YR
-
-